Melissa Krawczyk

1.3k total citations
13 papers, 821 citations indexed

About

Melissa Krawczyk is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Melissa Krawczyk has authored 13 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Melissa Krawczyk's work include Erythropoietin and Anemia Treatment (6 papers), PARP inhibition in cancer therapy (4 papers) and Connective tissue disorders research (3 papers). Melissa Krawczyk is often cited by papers focused on Erythropoietin and Anemia Treatment (6 papers), PARP inhibition in cancer therapy (4 papers) and Connective tissue disorders research (3 papers). Melissa Krawczyk collaborates with scholars based in United States, South Korea and Germany. Melissa Krawczyk's co-authors include Mark I. Talan, Edward G. Lakatta, Chanil Moon, Ismayil Ahmet, Doo‐Jin Paik, Dongchoon Ahn, Phillip F. Heller, Jing Zhang, Gaia Spinetti and Di Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Melissa Krawczyk

13 papers receiving 801 citations

Peers

Countries citing papers authored by Melissa Krawczyk

Since Specialization

Citations

This map shows the geographic impact of Melissa Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Krawczyk more than expected).

Fields of papers citing papers by Melissa Krawczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Krawczyk. The network helps show where Melissa Krawczyk may publish in the future.

Co-authorship network of co-authors of Melissa Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Krawczyk. A scholar is included among the top collaborators of Melissa Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Krawczyk. Melissa Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), Christopher H. Morrell, Jack M. Moen, (unknown), Melissa Krawczyk, Natalia Petrashevskaya, (unknown), (unknown), Irene Alfaras, Sarah J. Mitchell, Magdalena Juhaszova, Daniel R. Riordon, Mingyi Wang, Jing Zhang, Anthony Cerami, Michael Brines, Steven J. Sollott, Rafael de Cabo, Edward G. Lakatta	1
2	ARA290, A Small Non‐Hematopoietic Peptide Derived From Erythropoietin, Prolongs Healthspan And Attenuates Age‐Associated Declines In The Heart's Structure And Function 2018 ·The FASEB Journal ·(unknown), Jack M. Moen, (unknown), Melissa Krawczyk, Natalia Petrashevskaya, (unknown), (unknown), Irene Alfaras, Sarah J. Mitchell, Michel Bernier, Christopher Morrell, Steven J. Sollott, Magdalena Juhaszova, Rafael de Cabo, Edward G. Lakatta	1
3	Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes 2015 ·American Journal of Physiology-Heart and Circulatory Physiology ·Hyun‐Jin Tae, Natalia Petrashevskaya, Shannon Marshall, Melissa Krawczyk, Mark I. Talan	30
4	Doxycycline Ameliorates the Susceptibility to Aortic Lesions in a Mouse Model for the Vascular Type of Ehlers-Danlos Syndrome 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Wilfried Briest, Timothy K. Cooper, (unknown), Melissa Krawczyk, Nazli B. McDonnell, Mark I. Talan	19
5	The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome 2010 ·Veterinary Pathology ·Timothy K. Cooper, Qing Zhong, Melissa Krawczyk, (unknown), Gerd A. Müller, Ralf Schubert, Loretha Myers, Harry C. Dietz, Mark I. Talan, Wilfried Briest	33
6	Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Ismayil Ahmet, Melissa Krawczyk, Weizhong Zhu, Anthony Yiu‐Ho Woo, Christopher Morrell, Suresh Poosala, (unknown), Edward G. Lakatta, Mark I. Talan	56
7	The Pro-angiogenic Cytokine Pleiotrophin Potentiates Cardiomyocyte Apoptosis through Inhibition of Endogenous AKT/PKB Activity 2007 ·Journal of Biological Chemistry ·Jinliang Li, Hong Wei, Alan Chesley, Chanil Moon, Melissa Krawczyk, Maria Volkova, Bruce D. Ziman, Kenneth B. Margulies, Mark I. Talan, Michael T. Crow, Kenneth R. Boheler	33
8	Therapeutic Effectiveness of a Single vs Multiple Doses of Erythropoietin After Experimental Myocardial Infarction in Rats 2006 ·Cardiovascular Drugs and Therapy ·Chanil Moon, Melissa Krawczyk, Edward G. Lakatta, Mark I. Talan	16
9	Erythropoietin, Modified to Not Stimulate Red Blood Cell Production, Retains Its Cardioprotective Properties 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Chanil Moon, Melissa Krawczyk, Doo‐Jin Paik, Thomas R. Coleman, Michael Brines, Magdalena Juhaszova, Steven J. Sollott, Edward G. Lakatta, Mark I. Talan	73
10	Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats 2005 ·American Journal Of Pathology ·Mingyi Wang, Jing Zhang, Gaia Spinetti, Liqun Jiang, Robert E. Monticone, Di Zhao, Linda Cheng, Melissa Krawczyk, Mark I. Talan, Gianfranco Pintus, Edward G. Lakatta	143
11	Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window 2005 ·Cardiovascular Drugs and Therapy ·Chanil Moon, Melissa Krawczyk, Doo‐Jin Paik, Edward G. Lakatta, Mark I. Talan	58
12	Beneficial Effects of Chronic Pharmacological Manipulation of β-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy 2004 ·Circulation ·Ismayil Ahmet, Melissa Krawczyk, Phillip F. Heller, Chanil Moon, Edward G. Lakatta, Mark I. Talan	99
13	Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats 2003 ·Proceedings of the National Academy of Sciences ·Chanil Moon, Melissa Krawczyk, Dongchoon Ahn, Ismayil Ahmet, Doo‐Jin Paik, Edward G. Lakatta, Mark I. Talan	259

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact